Target Price | JPY5,806.25 |
Price | JPY5,314.00 |
Potential |
9.26%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target Kobayashi Pharmaceutical 2025 .
The average Kobayashi Pharmaceutical target price is JPY5,806.25.
This is
9.26%
register free of charge
JPY7,000.00
31.73%
register free of charge
JPY4,900.00
7.79%
register free of charge
|
|
A rating was issued by 8 analysts: 1 Analysts recommend Kobayashi Pharmaceutical to buy, 6 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Kobayashi Pharmaceutical stock has an average upside potential 2025 of
9.26%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion JPY | 173.46 | 168.90 |
4.33% | 2.62% | |
EBITDA Margin | 18.36% | 19.09% |
4.23% | 4.00% | |
Net Margin | 11.49% | 7.17% |
0.99% | 37.61% |
8 Analysts have issued a sales forecast Kobayashi Pharmaceutical 2024 . The average Kobayashi Pharmaceutical sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Kobayashi Pharmaceutical EBITDA forecast 2024. The average Kobayashi Pharmaceutical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Kobayashi Pharmaceutical Analysts have issued a net profit forecast 2024. The average Kobayashi Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share JPY | 268.16 | 162.94 |
3.29% | 39.24% | |
P/E | 32.61 | |
EV/Sales | 2.04 |
4 Analysts have issued a Kobayashi Pharmaceutical forecast for earnings per share. The average Kobayashi Pharmaceutical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Kobayashi Pharmaceutical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Kobayashi Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.